S81999 |
Lusutrombopag |
源叶(MedMol) | 98% |
- 提示:详情请下载说明书。
- 产品描述: Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist, used for treatment of chronic liver disease.
- 靶点: Thrombopoietin Receptor;Thrombin; ThrombopoietinReceptor
- 体外研究:
Lusutrombopag acts selectively on the human TPO receptor and activates signal transduction pathways that promote the proliferation and differentiation of bone marrow cells into megakaryocytes, thereby increasing platelet levels
- 参考文献:
1. Kim ES, et al. Lusutrombopag: First Global Approval. Drugs. 2016 Jan;76(1):155-8.
- 溶解性: soluble in DMSO
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 1.69 ml 8.452 ml 16.905 ml 5 mM 0.338 ml 1.69 ml 3.381 ml 10 mM 0.169 ml 0.845 ml 1.69 ml 50 mM 0.034 ml 0.169 ml 0.338 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)